Associated Papers
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms.
Sperling AS et al.
Blood, 2022
35512188 (PubMed )
Supplement: BLOOD_BLD-2021-014956-mmc1.pdf
Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia.
Li MJ et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi, 2016
Select a paper to view details